VREX Varex Imaging Corp
Electronic Components, NEC · Nasdaq · SEC CIK 1681622 · Fiscal year ends 10/02
Financial factors as of 2026-07-03 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.3%
TTM net income YoY116.7%
TTM EPS YoY116.3%
Revenue 3-yr CAGR-1.2%
Net income 3-yr CAGR-9.1%
Margins
Gross margin34.3%
Operating margin8.3%
Net margin2.6%
FCF margin-2.3%
EBITDA margin11.0%
Returns
ROE4.6%
ROA2.0%
ROIC (approx.)8.2%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets53.6%
Debt / equity0.70x
Current ratio3.38x
Interest coverage1.86x
Cash quality & payout
Operating cash flow / net income0.51x
Accruals ratio1.0%
Payout ratio—
Capex / revenue3.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-10-03 | FY20242024-09-27 |
|---|---|---|
| Income statement | ||
| Revenue | $844.60M | $811.00M |
| Cost of revenue | $554.10M | $554.10M |
| Gross profit | $290.50M | $256.90M |
| R&D expense | $91.10M | $87.00M |
| SG&A expense | $133.30M | $137.80M |
| Operating income | -$27.80M | $32.10M |
| Interest expense | $35.50M | $30.20M |
| Pretax income | -$59.20M | $5.00M |
| Income tax | $10.70M | $53.30M |
| Net income | -$70.30M | -$48.80M |
| EBITDA | -$4.60M | $53.30M |
| EPS (basic) | -1.70 | -1.20 |
| EPS (diluted) | -1.70 | -1.20 |
| Weighted avg. shares (diluted) | 41.40M | 40.80M |
| Balance sheet | ||
| Cash & equivalents | $145.00M | $168.70M |
| Short-term investments | $10.10M | $31.80M |
| Receivables | $156.60M | $157.70M |
| Inventory | $299.40M | $264.80M |
| Current assets | $641.80M | $649.90M |
| PP&E, net | $157.80M | $153.40M |
| Goodwill | $198.40M | $291.00M |
| Intangibles | $14.00M | $16.10M |
| Total assets | $1.11B | $1.21B |
| Current liabilities | $187.20M | $195.90M |
| Short-term debt | $1.50M | $46.30M |
| Long-term debt | $366.00M | $397.10M |
| Total debt | $367.50M | $443.40M |
| Total liabilities | $620.80M | $670.40M |
| Shareholders' equity | $472.60M | $529.10M |
| Net debt | $222.50M | $274.70M |
| Shares outstanding | 41.69M | 41.09M |
| Cash flow statement | ||
| Operating cash flow | $41.70M | $47.30M |
| Capital expenditure | $22.90M | $26.90M |
| Free cash flow | $18.80M | $20.40M |
| Investing cash flow | $10.30M | -$27.50M |
| Financing cash flow | -$75.90M | -$3.30M |
| Depreciation & amortization | $23.20M | $21.20M |
| Stock-based compensation | $15.00M | $15.30M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.